Access Resources
2411 - 2420 of 7540 Results
Title
Year
- High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosis2021RESTRICTEDTitle: High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosisJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 38Issue #:Start Page: 100988End Page: 100988Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2021.100988Best OA location URL: http://www.thelancet.com/article/S2589537021002686/pdfCitation Count: 67
-
RESTRICTEDTitle: Home Health Management of Parkinson Disease Deep Brain StimulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 8Start Page: 972End Page: 972Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.1910Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240011Citation Count: 13
-
RESTRICTEDTitle: In silico comparative analysis of LRRK2 interactomes from brain, kidney and lungJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1765Issue #:Start Page: 147503End Page: 147503Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2021.147503Best OA location URL: https://doi.org/10.1016/j.brainres.2021.147503Citation Count: 6
- Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease2021RESTRICTEDTitle: Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 8Start Page: 741End Page: 753Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlab056Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/8/741/40347160/nlab056.pdfCitation Count: 3
- Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment2021OPENTitle: Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatmentJournal Name: ExplorationPublisher: WileyVol: 1Issue #: 1Start Page: 35End Page: 49Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/exp.20210008Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/EXP.20210008Citation Count: 96
- Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons2021RESTRICTEDTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 17
- Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synuclein2021RESTRICTEDTitle: Preformed fibrils generated from mouse alpha-synuclein produce more inclusion pathology in rats than fibrils generated from rat alpha-synucleinJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 41End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.06.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429263Citation Count: 7
- Reply to: “Increased alpha‐Synuclein Level in CD45 + Blood Cells in Asymptomatic Carriers of GBA Mutations”2021RESTRICTEDTitle: Reply to: “Increased alpha‐Synuclein Level in CD45 + Blood Cells in Asymptomatic Carriers of GBA Mutations”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1998End Page: 1999Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28678Citation Count: 0
-
RESTRICTEDTitle: Reply to: “Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker?”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1999End Page: 2000Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28697Citation Count: 0
- Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial2021RESTRICTEDTitle: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 27Issue #: 8Start Page: 1451End Page: 1457Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-021-01455-xBest OA location URL: https://discovery.ucl.ac.uk/10134438/1/Dam%20%20%20%20PASSPORT%20Primary%20MS%20rev%20NMED-A110517A%20Final%20PIPE-18442%20w%20Figs.pdfCitation Count: 61